Loading...
No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls.
Schurink-Van't Klooster, T M ; Kemmeren, J M ; van der Maas, N A T ; van de Putte, E M ; Ter Wolbeek, M ; Nijhof, S L ; Vanrolleghem, A M ; van Vliet, J A ; Sturkenboom, M ; de Melker, H E
Schurink-Van't Klooster, T M
Kemmeren, J M
van der Maas, N A T
van de Putte, E M
Ter Wolbeek, M
Nijhof, S L
Vanrolleghem, A M
van Vliet, J A
Sturkenboom, M
de Melker, H E
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date of publication
2018-10-29
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls.
Translated Title
Published in
Vaccine 2018; 36(45):6796-802
Abstract
In 2013, the Netherlands Pharmacovigilance Center Lareb published an overview of reports of long-lasting fatigue following bivalent HPV-vaccination (2vHPV). After an update of this overview in 2015, concerns regarding the safety of 2vHPV was picked up by the media, which led to further reports of long-lasting fatigue. Therefore, the Dutch National Institute for Public Health and the Environment (RIVM) investigated a possible association between HPV-vaccination and long-term fatigue.
